Comments
Loading...

Franklin Genomic Advancements ETF

HELXBATS
Logo brought to you by Benzinga Data
$24.91
-1.43-5.44%
At close: -
$30.23
5.3221.38%
After Hours: Feb 24, 9:30 AM EDT

As of Feb 28, 2025

Number of Stock Holdings
62
Number of Bond Holdings
-
Total Holdings
62
Number of ETFs
-

Franklin Genomic Advancements ETF (BATS:HELX), Top Holdings

Franklin Genomic Advancements ETF (BATS: HELX)

TickerNameShare %
MEDPMedpace Holdings Inc3.48%
VRTXNvaesrtex Pharmaceuticals Inc4.58%
REGNRegeneron Pharmaceuticals, Inc.3.84%
DHRDanaher Corp.5.14%
TMOThermo Fisher Scientific Inc3.30%
KRYSKrystal Biotech Inc4.73%
LLYEli Lilly & Co.3.61%
KRSamsung Biologics Co Ltd3.74%
NTRANatera Inc5.62%
LNAstrazeneca Plc, ADR2.60%
UTHRUnited Therapeutics Corp3.18%
FFBiontech Se2.87%

FAQ

Q

How has HELX ETF performed?

A

The HELX ETF is currently trading at $24.91, which represents a -5.44% change. Over the past 52 weeks, the ETF has traded as high as $33.98 and as low as $26.34.

Q

What is the expense ratio for HELX?

A

The expense ratio of HELX is 0.5%. This represents the annual fee that all funds or ETFs charge their shareholders.

Q

What is the Assets Under Management (AUM) for HELX?

A

The total Assets Under Management (AUM) for HELX is 10.54M. This represents the total market value of the assets managed by the ETF.

Q

What is the investment style for HELX?

A

HELX follows a Mid Cap Growth investment style.

Q

What are the top holdings for HELX?

A

The top holdings of HELX include: MEDP (3.48%), VRTX (4.58%), REGN (3.84%), DHR (5.14%), TMO (3.3%). These represent the largest positions in the ETF's portfolio.

Q

What is the average daily trading volume for HELX?

A

Average daily volume data for HELX is currently not available.